Announcements Trials
Browse Landscape

Phase

Phase 1 8Phase 1/2 4Phase NA 1Phase EARLY_PHASE1 1Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Recurrence 4Multiple Myeloma 4Lymphoma 4Ovarian Neoplasms 3Burkitt Lymphoma 3Neoplasms, Plasma Cell 2Nasopharyngeal Carcinoma 2Lymphoma, T-Cell 2Leukemia, Myeloid, Acute 2Solid Tumors 1Solid Tumor 1Solid Cancer 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polyradiculoneuropathy, Chronic Inflammatory Demyelinating 1POEMS Syndrome 1Neuromyelitis Optica 1Neuroblastoma 1Neoplasms, Neuroepithelial 1Neoplasms 1Neoplasm, Residual 1Neoplasm Metastasis 1Myositis 1Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease 1Myasthenia Gravis 1Multiple Sclerosis 1Metastatic Castration-resistant Prostate Cancer 1Melanoma 1Lymphoma, Mantle-Cell 1

Interventions

lenvatinib 3Magnetic Resonance Spectroscopy 3pembrolizumab 2gallium 68 PSMA-11 2Sorafenib 2Radiosurgery 2Cyclophosphamide 2Biopsy 268Ga-DKFZ-PSMA-11 2spartalizumab 1semaglutide 1peginterferon alfa-2b 1gadolinium ethoxybenzyl DTPA 1folfirinox 1fluoromisonidazole 1fludarabine 1atezolizumab 1alpha-2'-deoxythioguanosine 1Radiotherapy 1Propranolol 1Nivolumab 1Microscopy, Electron 1Indocyanine Green 1Ethiodized Oil 1Doxorubicin 1Cryosurgery 1CYT-6091 1Bevacizumab 1BO-112 13-(4-(2-fluoroethoxy)phenyl)-2-(3-methyl-2-(4-((2-sulfamoylbenzo(d)thiazol-6-yloxy)methyl)-1H-1,2,3-triazol-1-yl)butanamido)propanoic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Carcinoma, Hepatocellular × fludarabine × Clear all
NCT06652243 2024-11-25

SN301A

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Phase EARLY_PHASE1 Recruiting
12 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡